Determination of a new collagen type I α2 gene point mutation which causes a Gly640 Cys substitution in osteogenesis imperfecta and prenatal diagnosis by DNA hybridisation

M. Gomez-Lira, A. Sangalli, P. F. Pignatti, M. C. Digilio, A. Giannotti, E. Carnevale, M. Mottes

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The molecular defect responsible for a sporadic case of extremely severe (type II/ III) osteogenesis imperfecta was investigated. The mutation site was localised in the collagen type I proα2 mRNA molecules produced by the proband's skin fibroblasts by chemical cleavage of mismatch in heteroduplex nucleic acids. Reverse transcription-polymerase chain reaction DNA amplification, followed by cloning and sequencing, showed heterozygosity for a G to T transversion in the first nucleotide of exon 37 of the COL1A2 gene, which led to a cysteine for glycine substitution at position 640 of the triple helical domain. This newly characterised mutation is localised in a domain which contains several milder mutations, confirming that glycine substitutions within the α2(I) chain do not follow a linear gradient pattern for genotype to phenotype correlations. In a subsequent pregnancy, absence of the G2327T mutation in the fetus was shown by allele specific oligonucleotide hybridisation to the trophoblast derived fibroblast mRNA after reverse transcription and in vitro amplification. (The nucleotide number assigned to the mutant base was inferred from the numbering system devised by the Osteogenesis Imperfecta Analysis Consortium.)

Original languageEnglish
Pages (from-to)965-968
Number of pages4
JournalJournal of Medical Genetics
Volume31
Issue number12
Publication statusPublished - 1994

Fingerprint

Osteogenesis Imperfecta
Collagen Type II
Prenatal Diagnosis
Point Mutation
Mutation
DNA
Glycine
Genes
Reverse Transcription
Nucleotides
Fibroblasts
Nucleic Acid Heteroduplexes
Messenger RNA
Trophoblasts
Genetic Association Studies
Collagen Type I
Oligonucleotides
Cysteine
Organism Cloning
Exons

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Determination of a new collagen type I α2 gene point mutation which causes a Gly640 Cys substitution in osteogenesis imperfecta and prenatal diagnosis by DNA hybridisation. / Gomez-Lira, M.; Sangalli, A.; Pignatti, P. F.; Digilio, M. C.; Giannotti, A.; Carnevale, E.; Mottes, M.

In: Journal of Medical Genetics, Vol. 31, No. 12, 1994, p. 965-968.

Research output: Contribution to journalArticle

@article{52e02d1c915948dc97c9802a567eba05,
title = "Determination of a new collagen type I α2 gene point mutation which causes a Gly640 Cys substitution in osteogenesis imperfecta and prenatal diagnosis by DNA hybridisation",
abstract = "The molecular defect responsible for a sporadic case of extremely severe (type II/ III) osteogenesis imperfecta was investigated. The mutation site was localised in the collagen type I proα2 mRNA molecules produced by the proband's skin fibroblasts by chemical cleavage of mismatch in heteroduplex nucleic acids. Reverse transcription-polymerase chain reaction DNA amplification, followed by cloning and sequencing, showed heterozygosity for a G to T transversion in the first nucleotide of exon 37 of the COL1A2 gene, which led to a cysteine for glycine substitution at position 640 of the triple helical domain. This newly characterised mutation is localised in a domain which contains several milder mutations, confirming that glycine substitutions within the α2(I) chain do not follow a linear gradient pattern for genotype to phenotype correlations. In a subsequent pregnancy, absence of the G2327T mutation in the fetus was shown by allele specific oligonucleotide hybridisation to the trophoblast derived fibroblast mRNA after reverse transcription and in vitro amplification. (The nucleotide number assigned to the mutant base was inferred from the numbering system devised by the Osteogenesis Imperfecta Analysis Consortium.)",
author = "M. Gomez-Lira and A. Sangalli and Pignatti, {P. F.} and Digilio, {M. C.} and A. Giannotti and E. Carnevale and M. Mottes",
year = "1994",
language = "English",
volume = "31",
pages = "965--968",
journal = "Journal of Medical Genetics",
issn = "0022-2593",
publisher = "BMJ Publishing Group",
number = "12",

}

TY - JOUR

T1 - Determination of a new collagen type I α2 gene point mutation which causes a Gly640 Cys substitution in osteogenesis imperfecta and prenatal diagnosis by DNA hybridisation

AU - Gomez-Lira, M.

AU - Sangalli, A.

AU - Pignatti, P. F.

AU - Digilio, M. C.

AU - Giannotti, A.

AU - Carnevale, E.

AU - Mottes, M.

PY - 1994

Y1 - 1994

N2 - The molecular defect responsible for a sporadic case of extremely severe (type II/ III) osteogenesis imperfecta was investigated. The mutation site was localised in the collagen type I proα2 mRNA molecules produced by the proband's skin fibroblasts by chemical cleavage of mismatch in heteroduplex nucleic acids. Reverse transcription-polymerase chain reaction DNA amplification, followed by cloning and sequencing, showed heterozygosity for a G to T transversion in the first nucleotide of exon 37 of the COL1A2 gene, which led to a cysteine for glycine substitution at position 640 of the triple helical domain. This newly characterised mutation is localised in a domain which contains several milder mutations, confirming that glycine substitutions within the α2(I) chain do not follow a linear gradient pattern for genotype to phenotype correlations. In a subsequent pregnancy, absence of the G2327T mutation in the fetus was shown by allele specific oligonucleotide hybridisation to the trophoblast derived fibroblast mRNA after reverse transcription and in vitro amplification. (The nucleotide number assigned to the mutant base was inferred from the numbering system devised by the Osteogenesis Imperfecta Analysis Consortium.)

AB - The molecular defect responsible for a sporadic case of extremely severe (type II/ III) osteogenesis imperfecta was investigated. The mutation site was localised in the collagen type I proα2 mRNA molecules produced by the proband's skin fibroblasts by chemical cleavage of mismatch in heteroduplex nucleic acids. Reverse transcription-polymerase chain reaction DNA amplification, followed by cloning and sequencing, showed heterozygosity for a G to T transversion in the first nucleotide of exon 37 of the COL1A2 gene, which led to a cysteine for glycine substitution at position 640 of the triple helical domain. This newly characterised mutation is localised in a domain which contains several milder mutations, confirming that glycine substitutions within the α2(I) chain do not follow a linear gradient pattern for genotype to phenotype correlations. In a subsequent pregnancy, absence of the G2327T mutation in the fetus was shown by allele specific oligonucleotide hybridisation to the trophoblast derived fibroblast mRNA after reverse transcription and in vitro amplification. (The nucleotide number assigned to the mutant base was inferred from the numbering system devised by the Osteogenesis Imperfecta Analysis Consortium.)

UR - http://www.scopus.com/inward/record.url?scp=0028603362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028603362&partnerID=8YFLogxK

M3 - Article

VL - 31

SP - 965

EP - 968

JO - Journal of Medical Genetics

JF - Journal of Medical Genetics

SN - 0022-2593

IS - 12

ER -